期刊文献+

膀胱癌及其正常组织染色体缺失研究及其临床意义 被引量:1

Allelic loss of heterozygosity in normal urthelium of patients with bladder cancer
下载PDF
导出
摘要 目的探讨膀胱癌患者9号染色体及p53等位基因的杂合性缺失(LOH)与膀胱移行细胞癌(TCC)形成、进展之间的关系及其在早期诊断膀胱癌及复发检测中的价值。方法选取9、17号染色体的5个微卫星位点D9S283、D9S303、D9S304、D9S1751和TP53,采用特异引物进行PCR扩增及变性聚丙烯酰胺凝胶电泳-硝酸银染色方法对40例TCC患者手术切除的癌组织及癌旁正常组织进行微卫星分析。结果 40例癌组织中,36例(90%)分别有1~5个微卫星位点发生LOH,其中微卫星改变发生最高的位点是TP53,发生率为62.5%,其次为D9S283,发生率为42.5%。结论 9、17号染色体上的5个微卫星位点LOH参与了膀胱癌的发生,通过检测这5个位点的LOH,可以为膀胱癌的早期诊断提供一定的线索。 Objective To investigate the relationship between loss of heterozygosity(LOH) of allele loci on chromosomes 9 and P53 in Chinese and development of transitional cell carcinoma(TCC) of urinary bladder.Methods LOH was studied in the tumor tissues of 40 patients,with their normal tumor-adjacent bladder tissues as control,by means of PCR amplification of 5 polymorphic microsatellite DNA loci D9S283,D9S303,D9S304,and D9S1751 on chromosome 9 and TP53.Following silver staining,8% denaturing polyacrilamide gel electrophoresis was performed.Results 36(90%) TCCs showed LOH at one or more loci,and 26 TCCs showed LOH at 2 loci.There was no significant difference between superfacial TCC and invasive TCC at these loci.Conclusion LOH on chromosome 9 might be an early event of the genesis of TCC of bladder,and LOH on p53 might be related with progression of TCC.Racial difference may contribute to different LOH on chromosome 9 and p53 between Chinese people and others.The combination of markers D9S283,D9S303,D9S304,D9S1751 and TP53 enable us to detect 36 out 40 of bladder cancers(90%);This panel might be chosen for microsatellite analysis in bladder cancer of Chinese.
出处 《重庆医学》 CAS CSCD 北大核心 2011年第9期853-855,共3页 Chongqing medicine
关键词 膀胱肿瘤 等位基因 基因 p53 聚合酶链反应 urinary bladder neoplasms allele gene p53 polymerase chain reaction
  • 相关文献

参考文献15

  • 1Wong KK, Tsang YT, Chang YM, et al. Genomewide al lelie imbalance analysis of pediatric gliomas by single nu cleotide polymorphic allele array[J]. Cancer Res, 2006,66 (23) :11172-11180.
  • 2Soui'vinos G,Kazanis I,Delakas D,et al. Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 TSG[-J]. Urology, 2001,165 (1):249-252.
  • 3Stoehra R, Zietz S, Burger M. Deletions of Chromosomes 9 and 8p in Histologically Normal Urothelium of Pa- tientswith Bladder Cancer[J]. Eur Urol, 2007,47 (6): 58-63.
  • 4Bakkar AA, Wallerand H, Radvanyi F, et al. FGFR3 and TP53 gene mutations define two distinct pathways in- urothelial cell carcinoma of the bladder[J]. Cancer Res,2003,63(24):8108-8112.
  • 5Woodhouse EC,Chuaqui RF, l.iotta I.A. General mechanisms of metastasis[J]. Cancer, 1997,80 ( 8 Suppl) : S1529- 1537.
  • 6Frost P,Levin B. Cliniealimp licatios of metastatic process [J]. Lancet, 1992,339(20) :1458-1461.
  • 7Jemal A, Murray T,Ward E,et al. Cancer statistics[J]. CA Cancer J Clin,2005,55(2) :10 30. Habuchi T, Yoshida O, Knowles MA. A novel candidate tumour suppressor locus at 9q32--33.
  • 8in bladder cancer: localization of the cadidate region within a single 8 402 kb YAC[J]. Hum Mol Genet,1997,6(6):913-919.
  • 9Knobloch R, Hegele A, Brandt H, et al. Serum DNA and urine DNA altera tions of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis [J]. Int J Cancer,2001,94(1) :67-72.
  • 10Berger AP, Parson W, Stenazl A, et al. Microsatellite alter ations in human bladder Cancer: detection of tumor cells in urine sediment and tumor tissue[J]. Eur Urol,2002,41 (5):532-539.

二级参考文献11

  • 1徐鸿毅.原位尿流改道[J].现代泌尿外科杂志,2006,11(2):63-66. 被引量:12
  • 2Parkin MD, Bray F, Ferlay J, et al. Global Cancer Statistics, 2002[J]. CA Cancer J Clin, 2005,55 : 74.
  • 3Cella DF, Cherin EA. Quailty of fife duringan dafterea ncertr eatment[J]. Compr Ther, 1988,14 (5) :69.
  • 4Sgrov S. Health,quality of fife and cancer [J]. Intern Nur Rev, 2005,52 : 233.
  • 5Eva G,Doug C, Timothy W, et al. Family caregiver burden:re-suit sofa longitudinal study of breast cancer patient sand their principal care givers[J]. CMAJ, 2004,170 (12) :1795.
  • 6Ware JE, Snow KK, Kosinski M, et al. SF236 health survey manual and interpretation guide[M]. Boston, MA: The Health Institute, New England Medical Center, 1993: 1212.
  • 7Ware J, Gandek B. Overview of SF-36 health survey and the international quality of life assessment(IQOLA)project[J]. J Clin Epidemiol, 1998,51 ( 11) : 903.
  • 8黄宜,肿瘤防治研究,1999年,26卷,18页
  • 9Mao L,Science,1996年,271卷,659页
  • 10Mao L,Proc Nat Acad Sci SUA,1994年,91期,9871页

共引文献10

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部